P&S Mechanics

What P&S Mechanics does

P&S Mechanics (operating as P&S Robotics) is a South Korean medical robotics company that develops, manufactures, and sells gait rehabilitation robots under the Walkbot brand. Founded in 2006 and headquartered in Yeongdeungpo-gu, Seoul, the company pivoted from an early wearable-robot prototype to an exoskeleton architecture grounded in neuroplasticity-based rehabilitation, with the first commercial Walkbot_S shipping in 2011. Its product platform centers on a four-model lineup — Walkbot_S (adult standard), Walkbot_K (pediatric, for children 86-148 cm tall), Walkbot_G (modular with adult and pediatric modules swappable in 5-10 minutes), and Walkbot_P (premium export model) — each integrating over 2,000 components with proprietary 3-joint (hip, knee, ankle) training, automatic leg-length adjustment in 1mm increments, impedance control without physical torque sensors, dynamic counterweight compensation, 3D motion analysis, force plate measurement, and an optional 3D Active augmented-reality software module. The systems are classified as Class IIa medical devices under EU Regulation (EU) 2017/745.

The company monetizes primarily through direct hardware sales of Walkbot systems to hospitals and rehabilitation centers in South Korea and internationally, supplemented by PnS Care after-sales service contracts. Customers are healthcare providers treating stroke, spinal cord injury, brain tumor, multiple sclerosis, and cerebral palsy patients, with documented installations in South Korea, China (Peking University Hospital), Spain, Turkey, and an academic research partnership with KAIST. Distribution combines a Korean direct-sales field motion with export to 8+ countries (Germany, UAE, China, USA, Singapore, Malaysia, Spain, Turkey, Uzbekistan), supported by regional distributors such as Saudi Arabia's Shams and recurring participation in Medica, Arab Health, KIMES, and CMEF.

The broader operating model also includes long-term R&D collaborations with KIST, KAIST, GIST, and the Korean Intelligent Robotics Business Group (which produced the KIBO humanoid line), ongoing filings for medical-robot core technologies, and an active KOSDAQ IPO process that included an IR book published in December 2024, shareholder meetings through 2025-2026, and a rebranding from P&S Mechanics to P&S Robotics in June 2025. Headcount of 11-50 employees indicates the company remains an early-stage, growth-oriented commercialization-stage business rather than a scaled enterprise.

Name

P&S Mechanics

Legal name

P&S Mechanics Co., Ltd.

Website

https://walkbot.co.kr

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

P&S Mechanics (rebranded to P&S Robotics in 2025) is a South Korean medical robotics company that designs, manufactures, and sells the Walkbot line of gait rehabilitation exoskeleton robots (Walkbot_S, K, G, P) to hospitals and rehabilitation centers globally, with Class IIa EU MDR certification and international export to 8+ countries.

Ownership category

akta.pro rank

Product category

Medical Rehabilitation Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Healthcare & Assistive Robotics (HDAAAIAC)

akta.pro secondary industry

Robot Hardware, Actuators & Components (sensors, grippers, motors) (HDAAAIAL)

Keywords

• Gait rehabilitation robotics
• Medical exoskeleton devices
• Neurorehabilitation systems
• Pediatric rehabilitation robots
• EU Class IIa medical devices

Headquarters

HQ city

Yongdungpo

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales - Walkbot Systems: Sale of robotic gait rehabilitation systems (Walkbot_S, Walkbot_K, Walkbot_G, Walkbot_P) to hospitals, rehabilitation centers, and healthcare facilities. These are Class IIa medical devices under EU regulation (EU) 2017/745.
2. PnS Care After-Sales Service: After-sales service and support programs for installed Walkbot systems.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

P&S Mechanics (P&S Robotics) develops and manufactures the Walkbot line of robotic gait rehabilitation systems designed for clinical use in hospitals and rehabilitation centers. The portfolio includes adult (Walkbot_S), pediatric (Walkbot_K), modular (Walkbot_G), and premium export (Walkbot_P) gait training robots, complemented by 3D AR visualization, 3D Motion Analysis, and Force Plate measurement add-ons. Revenue is generated primarily through capital equipment sales to medical institutions, supported by the PnS Care after-sales service program.

Product overview

P&S Robotics (P&S Mechanics) offers the Walkbot gait rehabilitation robot system - a comprehensive portfolio of medical rehabilitation robots designed for patients with neurological or musculoskeletal conditions affecting mobility. The product line includes four main models: Walkbot_S (adult standard), Walkbot_K (pediatric), Walkbot_G (modular/adult-pediatric interchangeable), and Walkbot_P (premium export model). The systems are classified as Medical Device Class IIa under EU MDR 2017/745 and combine exoskeleton robotics with augmented reality, gait analysis, and AI-based performance optimization for personalized rehabilitation training.

Differentiator

Problem solved

Functional benefit

Brands

• Walkbot: Gait rehabilitation robot system product line including Walkbot_S (adult), Walkbot_K (pediatric), Walkbot_G (modular), and Walkbot_P (premium) models
• PnS Care

Products and services

• Walkbot_S (Superior)

Quantifiable outcome

• Natural gait pattern optimal to the patient
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature10 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Gwangju Institute of Science and Technology (GIST) - Convergence Technology InstitutecoreStrategic or Co-development Partner · 4 February 2025P&S Robotics signed a business partnership agreement with GIST Convergence Technology Institute for invited scholar support funding. The collaboration supports research and development in medical robotics technology.
• KIST (Korea Institute of Science and Technology)coreStrategic or Co-development PartnerLong-standing research collaboration with KIST on automation systems, design and manufacturing. Technology internalization through collaborative development projects.
• Intelligent Robotics Business GroupminorStrategic or Co-development PartnerSuccessfully developed humanoid robot (KIBO) for the Intelligent Robotics Business Group project, with subsequent versions (KIBO V1.1, V1.5, V2.0) and related robot hand technology.
• University-affiliated Research InstitutesminorStrategic or Co-development PartnerCollaborative research partnerships with various university-affiliated research institutes for technology development.
• Shams (Saudi Arabia Distributor)minorChannel Partner/ Reseller/ DistributorSaudi Arabian distribution partner for Walkbot products in the Middle East market, documented at Medica 2019.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Honda Walking Assist: Honda has developed the Walking Assist device, a wearable gait-assistive exoskeleton for stroke and elderly mobility rehabilitation. As part of a much larger global mobility conglomerate, Honda is a broad incumbent in robotic gait assistance that overlaps technologically with Walkbot's lower-limb robotics focus.

Direct peers

• Tyromotion (DIH Medical): Tyromotion, now part of DIH Medical alongside Hocoma, offers a portfolio of robotic and sensor-based rehab devices including gait, arm, and functional therapy. Its gait rehabilitation products target the same hospital/rehab-center buyers as Walkbot with overlapping clinical indications.
• Cyberdyne: Cyberdyne develops the HAL (Hybrid Assistive Limb) lower-limb exoskeleton, a pioneering neurorehabilitation robot that reads bioelectric signals to assist movement. It is a direct peer to Walkbot in the gait-rehabilitation robotics category, sharing clinical applications, hospital customers, and EU/Japan regulatory pathways.
• ReWalk Robotics: ReWalk Robotics produces powered exoskeleton systems (ReWalk Personal 6.0, ReStore soft exosuit) for spinal cord injury and stroke rehabilitation. Like P&S, it sells Class II medical-device exoskeletons to hospitals and rehabilitation centers worldwide, making it a direct gait-rehab robotics peer.
• Ekso Bionics: Ekso Bionics makes the Ekso GT, a wearable bionic exoskeleton used for gait rehabilitation after stroke, spinal cord injury, and orthopedic conditions. It directly competes with Walkbot in adult gait rehabilitation robotics for clinical settings and shares the same hospital/rehab-center buyer profile.
• Parker Hannifin (Indego): Parker Hannifin's Indego is a powered exoskeleton for gait rehabilitation and mobility assistance in clinical and personal settings. Sold to hospitals and rehab centers, Indego competes head-to-head with Walkbot in the powered lower-limb exoskeleton category for stroke and SCI recovery.
• Fourier Intelligence: Fourier Intelligence (Shanghai Fourier) builds the ExoMotus EMG-driven gait rehabilitation exoskeleton and RehabHub integrated platform. It is one of the most direct global peers to Walkbot in clinical lower-limb gait robotics, with comparable modular product architecture and a focus on hospital-grade systems.
• Hocoma (DIH Medical): Hocoma, now part of DIH Medical, manufactures the Lokomat — a treadmill-based robotic gait rehabilitation system widely considered the gold standard in clinical gait rehab. It is the closest direct peer to P&S Robotics' Walkbot in terms of clinical indication (lower-limb gait restoration), customer base (hospitals and rehab centers), and technology category.
• Bionik Laboratories: Bionik Laboratories produces the InMotion line of clinical robotics for upper and lower-limb rehabilitation, including InMotionARM and InMotionWALK. The InMotionWALK gait rehabilitation robot serves the same hospital rehab market as P&S's Walkbot systems, making it a direct comparable in clinical neurorehabilitation robotics.

Emerging players

• Marsi Bionics: Marsi Bionics is a Spanish medical robotics spin-off developing pediatric and adult gait-rehabilitation exoskeletons (e.g., ATLAS, MAK). It is an emerging player with similar clinical applications to Walkbot (especially in pediatric gait rehab, where P&S's Walkbot_K also operates), making it a thematically and product-overlap peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/p-s-robotics-co-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about P&S Mechanics